RONALD HUNT
CIK 1247851 · last filed 2026-02-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$33.80M
Companies
8
Total Filings
51
Lifetime Open-Market Net
$16.44M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RLYB | Director | 1,993,911 | $15.92 | $31.74M | $4.00M | 10 | 2026-02-20 |
| Iterum Therapeutics plc (ITRM) Delisted | Director | 268,244 | $0.03 | $8.0K | $8.61M | 18 | 2025-01-23 |
| Harpoon Therapeutics, Inc. (HARP) Delisted | Director | 13,224 | $23.01 | $304.3K | $20.00M | 17 | 2024-03-11 |
| STIM | Director | 1,543,962 | $1.33 | $2.05M | $0 | 2 | 2019-04-03 |
| Lite Strategy, Inc. (MEIP) Delisted | 10%+ Owner | 0 | $3.20 | $0 | -$25.28M | 1 | 2015-03-26 |
| Relypsa Inc (RLYP) Delisted | Director | 1,924,626 | — | — | $2.05M | 1 | 2013-11-20 |
| CDE | 10%+ Owner | 0 | $17.20 | $0 | $0 | 1 | 2012-08-06 |
| Durata Therapeutics, Inc. (DRTX) Delisted | Director | 3,028,439 | — | — | $7.06M | 1 | 2012-07-26 |
Recent Filings · Page 3 of 6
51 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-01-05 | RLYB | Grant (A) | — | $0 | EDGAR |
| 2023-01-04 | Iterum Therapeutics plc (ITRM) Delisted | Exer (M) | +1,197 | $0 | EDGAR |
| 2022-12-28 | Iterum Therapeutics plc (ITRM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-09-27 | Iterum Therapeutics plc (ITRM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-28 | Iterum Therapeutics plc (ITRM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-24 | Iterum Therapeutics plc (ITRM) Delisted | Exer (M) | +36,798 | $0 | EDGAR |
| 2022-06-24 | Harpoon Therapeutics, Inc. (HARP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-17 | Iterum Therapeutics plc (ITRM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-26 | RLYB | Grant (A) | — | $0 | EDGAR |
| 2022-03-29 | Iterum Therapeutics plc (ITRM) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.